CHRS
#3570
Coherus Oncology, Inc. - Common Stock
1.3 9 USD
-0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-2.11%
Changement Mensuel
-4.79%
Evolution sur 6 mois
-17.26%
Changement Annuel
-13.66%
Clôture Précédente
1.4 2
Open
1.3 9
Low
1.3 9
High
1.4 0
Volume
50
Financials
- Market Capitalization 214.76 M
- Employee 144
- Founded 2010
- CEO Dennis Lanfear
- Website www.coherus.com
- Headquarter Delaware, United States
- FIGI BBG0063N8V69
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
0.99
ratio cours/chiffre d'affaires
3.94
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3563 |  RNA Atrium Therapeutics, Inc. - Common Stock | 13.44 USD | +1.82% | +4.75% | +15.76% | -80.89% | 229.90 M USD | ||
| 3566 |  ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 3.10 USD | -1.90% | +16.54% | +41.55% | +103.95% | 224.18 M USD | ||
| 3572 |  PEPG PepGen Inc. - Common Stock | 3.18 USD | +1.27% | +6.35% | +63.08% | +140.91% | 220.25 M USD | ||
| 3573 |  BCYC Bicycle Therapeutics plc - American Depositary Shares | 4.36 USD | -0.23% | +10.38% | +11.79% | -38.59% | 220.42 M USD |